Literature DB >> 26946648

Use of closed-system drug transfer devices in the handling and administration of MABs.

Elizabeth Meade.   

Abstract

There is a lack of research and consensus on the long-term risks of occupational exposure to monoclonal antibodies. There is, however, some risk to health professionals who are involved in their preparation and administration. This article discusses the use of closed-system drug transfer devices to minimise exposure, and touches on the importance of aseptic techniques, personal protective equipment, and appropriate education and training for health professionals.

Mesh:

Substances:

Year:  2015        PMID: 26946648     DOI: 10.12968/bjon.2015.24.sup16a.s21

Source DB:  PubMed          Journal:  Br J Nurs        ISSN: 0966-0461


  2 in total

1.  Evaluation of Different Quality-Relevant Aspects of Closed System Transfer Devices (CSTDs).

Authors:  Ahmed Besheer; Hanns-Christian Mahler; Anja Matter-Schwald; Sergio Mompart Barrenechea; Martin Vogt; Pascal Chalus; Pauline Heymes; Timothy Pillow; Andrea Kirste; Patrick Favrod; Susanne Joerg; Roman Mathaes
Journal:  Pharm Res       Date:  2020-04-09       Impact factor: 4.200

Review 2.  Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff.

Authors:  Kurinchi Selvan Gurusamy; Lawrence Mj Best; Cynthia Tanguay; Elaine Lennan; Mika Korva; Jean-François Bussières
Journal:  Cochrane Database Syst Rev       Date:  2018-03-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.